- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Fonar targets neurosurgeons
MR pioneer Fonar sought new customers at the American Association of Neurological Surgeons meeting May 3 to 5 in Orlando, FL. The meeting attracted about 3000 neurosurgeons and related healthcare professionals. Fonar's 30 x 50-foot exhibit featured a
MR pioneer Fonar sought new customers at the American Association of Neurological Surgeons meeting May 3 to 5 in Orlando, FL. The meeting attracted about 3000 neurosurgeons and related healthcare professionals. Fonar's 30 x 50-foot exhibit featured a full-size mockup of the company's Stand-Up MRI. Fonar has been actively courting specialists outside radiology, notably orthopedic surgeons, who might benefit from the ability of the Stand-Up scanner to visualize the spine under normal weight-bearing conditions.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
